@eriksosa2011 Cancer de Hígado. https://t.co/U6eWUIX7PS
@DaveHarman13 @ebtapper @ZGordonJiang @HepCommJournal @AdamMikMD @AASLDtweets @GIChiefNid @BIDMC_GI @MichiganLiver Not very different to what we found in the paper. Risk of finding >12 kPa negligible, though. Others found (in over 60,000 patients) that
https://t.co/0sMFp2iPmq @genfit_pharma @NASH_Education
RT @sidiapdatabase: New paper! And nice collaborative work on predictors of cirrhosis and hepatocellular carcinoma 👉 https://t.co/x5BhuRO…
RT @sidiapdatabase: New paper! And nice collaborative work on predictors of cirrhosis and hepatocellular carcinoma 👉 https://t.co/x5BhuRO…
RT @sidiapdatabase: New paper! And nice collaborative work on predictors of cirrhosis and hepatocellular carcinoma 👉 https://t.co/x5BhuRO…
New paper! And nice collaborative work on predictors of cirrhosis and hepatocellular carcinoma 👉 https://t.co/x5BhuROoiC IPCI Database @ucl_thin @erasmusmcintl #EHR @IDIAPJGol #primarycare
Faculty Member @HelmySiragy recommends “Risks & clinical predictors of cirrhosis & hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in 4 European cohorts.” @WillAlazawi #BartsLiverCentre htt
RT @IDIAPJGol: 'Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-worl…
RT @InfoCancerFoie: A real-world study of 18 million patients in 4 European cohorts shows that recorded diagnosis of #NAFLD/#NASH increases…
A real-world study of 18 million patients in 4 European cohorts shows that recorded diagnosis of #NAFLD/#NASH increases risk of life-threatening #liver outcomes & #Diabetes is an independent predictor of advanced #liverdisease #diagnosis https://t.co/X
RT @IDIAPJGol: 'Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-worl…
RT @IDIAPJGol: 'Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-worl…
'Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts' IDIAPJGol at @BioMedCentral https://t.co/6O1B2LvEwf cc @TDuarte_Salles @pr
New from #The_MRC https://t.co/odtjeYiOL0 Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
RT @kamleshkhunti: Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carci…
@Nirantharakumar @anuradhaa_s
Real-world population data show that recorded diagnosis of NAFLD/NASH increases risk of cirrhosis & hepatocellular carcinoma https://t.co/gtEInPr5GN @LRWEUnit @DSNforumUK @youngdiab @ADA_DiabetesPro @DiabetesCanada @AmDiabetesAssn @AmarPut @AbdTahran
RT @Statofish: Not a surprise to those working in Hepatology not sure why diabetes have yet to wake up to the idea of fibroscanning patien…
Not a surprise to those working in Hepatology not sure why diabetes have yet to wake up to the idea of fibroscanning patients to detect liver fat and prevent many from going onto medications they don’t need if they have an opportunity to change earlier in
RT @carreau_anne: Risks and clinical predictors of #cirrhosis and #hepatocellular carcinoma diagnoses in adults with diagnosed #NAFLD: real…
RT @carreau_anne: Risks and clinical predictors of #cirrhosis and #hepatocellular carcinoma diagnoses in adults with diagnosed #NAFLD: real…
Risks and clinical predictors of #cirrhosis and #hepatocellular carcinoma diagnoses in adults with diagnosed #NAFLD: real-world study of 18 million patients in four European cohorts Type 2 #Diabetes: strongest association with the risk of cirrhosis/HCC
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts | BMC Medicine | Full Text https://t.co/b3guMvANTy
RT @prieto_alhambra: New paper in @BMCMedicine “Risks and Predictors of Cirrhosis and Hepatocellular Carcinoma in Adults With Diagnosed N…
New paper in @BMCMedicine “Risks and Predictors of Cirrhosis and Hepatocellular Carcinoma in Adults With Diagnosed NAFLD: Real-World Study of 18 Million Patients in 4 European Cohorts” @CSMOxford @sidiapdatabase #openaccess https://t.co/WdnxOstFXK
Study is here: https://t.co/y0p9Jzb48F
RT @WillAlazawi: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-wor…
RT @WillAlazawi: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-wor…
New research article! Risks and clinical predictors of #cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed #NAFLD: real-world study of 18 million #patients in four European cohorts https://t.co/UR5MwgTGAm https://t.co/JJlGBbYLsI
RT @WillAlazawi: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-wor…
RT @WillAlazawi: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-wor…
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts https://t.co/QpVANPghzM #